Related Articles for PubMed (Select 15251043)

Tumor-infiltrating effector cells of alpha-galactosylceramide-induced antitumor immunity in metastatic liver tumor.

Osada T, Nagawa H, Shibata Y.

J Immune Based Ther Vaccines. 2004 Jul 13;2(1):7.

PMID: 15251043 [PubMed - as supplied by publisher]

Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice.

Nakagawa R, Nagafune I, Tazunoki Y, Ehara H, Tomura H, Iijima R, Motoki K, Kamishohara M, Seki S.

J Immunol. 2001 Jun 1;166(11):6578-84.

PMID: 11359810 [PubMed - indexed for MEDLINE]

The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.

Nishimura T, Kitamura H, Iwakabe K, Yahata T, Ohta A, Sato M, Takeda K, Okumura K, Van Kaer L, Kawano T, Taniguchi M, Nakui M, Sekimoto M, Koda T.

Int Immunol. 2000 Jul;12(7):987-94.

PMID: 10882410 [PubMed - indexed for MEDLINE]

Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.

Fujii S, Shimizu K, Hemmi H, Steinman RM.

Immunol Rev. 2007 Dec;220:183-98. Review.

PMID: 17979847 [PubMed - indexed for MEDLINE]

Essential role of bystander cytotoxic CD122+CD8+ T cells for the antitumor immunity induced in the liver of mice by alpha-galactosylceramide.

Nakagawa R, Inui T, Nagafune I, Tazunoki Y, Motoki K, Yamauchi A, Hirashima M, Habu Y, Nakashima H, Seki S.

J Immunol. 2004 Jun 1;172(11):6550-7.

PMID: 15153469 [PubMed - indexed for MEDLINE]

Decreased expressions of CD1d molecule on liver dendritic cells in subcutaneous tumor bearing mice.

Tatsumi T, Takehara T, Yamaguchi S, Sasakawa A, Yamamoto M, Fujita Y, Miyagi T, Ohkawa K, Hayashi N.

J Hepatol. 2008 Nov;49(5):779-786. Epub 2008 Jul 2.

PMID: 18760855 [PubMed - as supplied by publisher]

Neutralization of tumor necrosis factor abrogates hepatic failure induced by alpha-galactosylceramide without attenuating its antitumor effect in aged mice.

Inui T, Nakashima H, Habu Y, Nakagawa R, Fukasawa M, Kinoshita M, Shinomiya N, Seki S.

J Hepatol. 2005 Oct;43(4):670-8.

PMID: 15922476 [PubMed - indexed for MEDLINE]

Tumor cells loaded with alpha-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice.

Shimizu K, Goto A, Fukui M, Taniguchi M, Fujii S.

J Immunol. 2007 Mar 1;178(5):2853-61.

PMID: 17312129 [PubMed - indexed for MEDLINE]

Therapeutic effect of alpha-galactosylceramide-loaded dendritic cells genetically engineered to express SLC/CCL21 along with tumor antigen against peritoneally disseminated tumor cells.

Matsuyoshi H, Hirata S, Yoshitake Y, Motomura Y, Fukuma D, Kurisaki A, Nakatsura T, Nishimura Y, Senju S.

Cancer Sci. 2005 Dec;96(12):889-96.

PMID: 16367909 [PubMed - indexed for MEDLINE]

10:

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.

Kitamura H, Iwakabe K, Yahata T, Nishimura S, Ohta A, Ohmi Y, Sato M, Takeda K, Okumura K, Van Kaer L, Kawano T, Taniguchi M, Nishimura T.

J Exp Med. 1999 Apr 5;189(7):1121-8.

PMID: 10190903 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

11:

Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer.

Hattori T, Kokura S, Okuda T, Okayama T, Takagi T, Handa O, Naito Y, Yoshida N, Yoshikawa T.

Int J Hyperthermia. 2007 Nov;23(7):591-8.

PMID: 18038289 [PubMed - indexed for MEDLINE]

12:

IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, alpha-galactosylceramide.

Hayakawa Y, Takeda K, Yagita H, Smyth MJ, Van Kaer L, Okumura K, Saiki I.

Blood. 2002 Sep 1;100(5):1728-33.

PMID: 12176894 [PubMed - indexed for MEDLINE]

13:

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.

Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, Ritter G, Schmidt R, Harris AL, Old L, Cerundolo V.

J Immunol. 2003 Nov 15;171(10):5140-7.

PMID: 14607913 [PubMed - indexed for MEDLINE]

14:

Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.

Hayakawa Y, Takeda K, Yagita H, Kakuta S, Iwakura Y, Van Kaer L, Saiki I, Okumura K.

Eur J Immunol. 2001 Jun;31(6):1720-7.

PMID: 11385616 [PubMed - indexed for MEDLINE]

15:

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

Kakimi K, Guidotti LG, Koezuka Y, Chisari FV.

J Exp Med. 2000 Oct 2;192(7):921-30.

PMID: 11015434 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

16:

alpha-Galactosylceramide-loaded, antigen-expressing B cells prime a wide spectrum of antitumor immunity.

Kim YJ, Ko HJ, Kim YS, Kim DH, Kang S, Kim JM, Chung Y, Kang CY.

Int J Cancer. 2008 Jun 15;122(12):2774-83.

PMID: 18338753 [PubMed - indexed for MEDLINE]

17:

Potentiation of antitumor effect of NKT cell ligand, alpha-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells.

Nakui M, Ohta A, Sekimoto M, Sato M, Iwakabe K, Yahata T, Kitamura H, Koda T, Kawano T, Makuuchi H, Taniguchi M, Nishimura T.

Clin Exp Metastasis. 2000;18(2):147-53.

PMID: 11235990 [PubMed - indexed for MEDLINE]

18:

Effects of cyclosporin A on the activation of natural killer T cells induced by alpha-galactosylceramide.

Kajiwara T, Tomita Y, Okano S, Iwai T, Yasunami Y, Yoshikai Y, Nomoto K, Yasui H, Tominaga R.

Transplantation. 2007 Jan 27;83(2):184-92.

PMID: 17264815 [PubMed - indexed for MEDLINE]

19:

Age-associated augmentation of the synthetic ligand- mediated function of mouse NK1.1 ag(+) T cells: their cytokine production and hepatotoxicity in vivo and in vitro.

Inui T, Nakagawa R, Ohkura S, Habu Y, Koike Y, Motoki K, Kuranaga N, Fukasawa M, Shinomiya N, Seki S.

J Immunol. 2002 Dec 1;169(11):6127-32.

PMID: 12444115 [PubMed - indexed for MEDLINE]

20:

Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer.

Smyth MJ, Wallace ME, Nutt SL, Yagita H, Godfrey DI, Hayakawa Y.

J Exp Med. 2005 Jun 20;201(12):1973-85. Erratum in: J Exp Med. 2005 Aug 15;202(4):569.

PMID: 15967825 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Recent Activity